311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.

Ferrari, M D

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists. [electronic resource] - Neurology Mar 1997 - S21-4 p. digital

Publication Type: Comparative Study; Journal Article; Review

0028-3878

10.1212/wnl.48.3_suppl_3.21s doi


Headache--drug therapy
Humans
Migraine Disorders--drug therapy
Oxazoles--adverse effects
Oxazolidinones
Receptor, Serotonin, 5-HT1B
Receptor, Serotonin, 5-HT1D
Receptors, Serotonin--physiology
Serotonin Receptor Agonists--adverse effects
Tryptamines